Soft Chew Economics: Why Format Choice Drives Ingredient Quality Budgets

Our Investigations Desk —

On this page
  1. Key Takeaways
  2. The Excipient Problem: What Fills the Chew
  3. The Heat Problem: Thermal Processing and Live Cultures
  4. The Margin Problem: How Format Profitability Shapes Quality Ceilings
  5. Format Comparison: What the Economics Allow
  6. What This Means for the Shelf-Stability Investigation
Disclosure: This site is reader-supported. When you buy through links on our site, we may earn an affiliate commission at no additional cost to you. We independently research and evaluate every product we cover. Some brands we feature are affiliate partners, which means we may be compensated if you purchase through our links. This compensation never dictates our editorial ratings; our recommendations are based on ingredient evidence, published research, and transparent criteria. See our Editorial Policy and full Affiliate Disclosure for details.

Key Takeaways

  • Soft chew supplements carry roughly 40–60% excipient load by weight, which directly squeezes the budget available for active ingredients.
  • Heat extrusion (tunnel ovens typically running 130–160°F) and moisture control (water activity targets of 0.6 or below) impose hard limits on how much live bacterial culture a chew can deliver.
  • Format economics explain why identical label claims cost radically different amounts to produce — and why “30 billion CFU” on a soft chew label is a fundamentally different proposition than the same claim on a powder or capsule.
  • Postbiotic formats (heat-treated bacterial metabolites) sidestep every thermal and moisture constraint of soft chew manufacturing, which is a structural advantage rather than a marketing talking point.
  • Consumers comparing dog supplements should weight format choice at least as heavily as label claims, because the format determines what can physically be inside the product.

Walk into any pet supply store and the soft chew format dominates the shelf. The format is convenient, palatable, and easy to administer — but soft chew manufacturing economics impose constraints that no amount of marketing can overcome. The choice of format determines the ceiling on ingredient quality, and the difference between a powder, a capsule, and a soft chew is the difference between a $4 manufacturing cost per kilogram and a $40 one. This investigation traces the supply chain logic that shapes what actually ends up in the bag.

Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.

Diagram of soft chew manufacturing process showing ingredient blending, extrusion, and drying stages

The Excipient Problem: What Fills the Chew

Every soft chew is mostly not the active ingredient. Industry formulation data and contract manufacturer spec sheets consistently show that excipients — the binders, fillers, flavors, and structural carbohydrates that hold a chew together — account for 40–60% of finished product weight. A typical 5-gram chew delivering a meaningful probiotic dose might contain 2.5 grams of flour, glycerin, molasses, and palm oil before a single gram of active culture is added.

This is not deception. It is physics. A chew needs structural integrity, palatability, shelf stability, and a moisture profile that prevents microbial overgrowth. Each of those requirements costs excipient mass. When the excipient budget consumes half the formula, the active-ingredient budget is correspondingly halved.

Where the money actually goes

Contract manufacturers price soft chew production by ingredient cost plus processing margin. High-volume excipients (wheat flour, rice flour, glycerin) run $1–3 per kilogram. Specialized actives — coated probiotic blends, postbiotic preparations, enzyme complexes — run $50–500 per kilogram. The arithmetic is unforgiving. A formula that allocates 50% of its mass to excipients has, at best, 50% of its cost budget available for the ingredients that actually do something.

For a product claiming “30 billion CFU per chew,” the cost of the probiotic blend alone can exceed the cost of every other ingredient combined. That is why many soft chew probiotics use low-cost single-strain Enterococcus faecium rather than multi-strain Lactobacillus/Bifidobacterium blends — the strain choice is driven by what fits the excipient-constrained budget, not by what the evidence base prefers.

Moisture and water activity targets

Soft chews target a water activity (aw) of 0.6 or below to prevent mold and bacterial overgrowth during shelf life. Achieving that target requires either extensive drying (which removes mass and concentrates actives) or humectants like glycerin (which add excipient mass). Either way, the moisture control requirement consumes a fixed share of the formula budget that cannot be redirected to actives.

The Heat Problem: Thermal Processing and Live Cultures

Soft chew manufacturing typically involves tunnel oven drying at 130–160°F for several hours, sometimes followed by a secondary conditioning phase. These temperatures are well above the thermal tolerance threshold of most probiotic organisms. Lactobacillus species begin showing viability loss above 100°F; Bifidobacterium is even more sensitive.

Manufacturers address this through two strategies, each with its own economic cost:

  • Overdosing: Adding far more culture at production than the label claim, hoping enough survives processing. This inflates the active-ingredient budget by 3–10× depending on the organism and process temperature.
  • Encapsulation: Coating individual bacterial cells in lipid or protein matrices that protect them during heat exposure. Encapsulation adds $20–80 per kilogram to the ingredient cost, but improves survival rates substantially.

Neither strategy is perfect. Independent testing has repeatedly shown that soft chew probiotic labels frequently overstate viable CFU at the point of consumption — a problem our previous investigation into 30 billion CFU claims documented in detail.

Why postbiotics sidestep the thermal constraint

Postbiotics — heat-treated bacterial metabolites, cellular fragments, and inactivated whole cells — are by definition not alive. The manufacturing process that would destroy a probiotic is the manufacturing process that creates a postbiotic. This is a structural advantage rather than a marketing claim. A postbiotic ingredient can survive any temperature a soft chew line can produce, without overdosing or encapsulation.

The economic implication is straightforward: postbiotic actives cost less to incorporate into a soft chew format because they require none of the thermal-mitigation investment that live cultures demand. Whether this translates to better products depends entirely on the evidence base for the specific postbiotic — but the format-level cost advantage is real.

The Margin Problem: How Format Profitability Shapes Quality Ceilings

Soft chews command premium retail prices relative to powders and capsules, often 3–5× higher per dose. Retail margins on soft chews in the pet supplement category commonly run 50–70%, reflecting consumer willingness to pay for convenience. But high retail margins do not automatically translate to higher ingredient budgets at the manufacturing stage.

The competitive pressure in soft chews pushes in two directions simultaneously. Premium-positioned brands can afford higher active-ingredient costs because their retail price supports the input. Mass-market brands face a ceiling: if the retail price is $25 for a 60-count bottle, the wholesale price is roughly $12–15, and the manufacturer must hit a cost-of-goods target of $4–6 per bottle to maintain viability. That leaves very little room for expensive actives.

Comparison chart showing ingredient budget allocation across soft chew, powder, and capsule supplement formats

The contract manufacturing reality

Most pet supplement brands do not own manufacturing facilities. They contract with specialty co-packers who run dozens of brands on shared equipment lines. Contract pricing follows volume tiers and ingredient complexity. A simple flour-and-glycerin base chew might cost $3–5 per kilogram to produce; a chew with coated probiotics, enzymes, and specialized flavors might cost $15–25 per kilogram.

For brands selling at $25 retail, the production cost difference between a basic chew and a complex one can exceed the entire wholesale margin. This is the structural reason why so many soft chew products are, at the formulation level, remarkably similar — the format rewards simplicity, and simplicity rewards low-cost excipient stacks with modest active doses.

Format Comparison: What the Economics Allow

Format Excipient Load Active Ingredient Budget Thermal Constraints on Actives Typical Cost-Per-Dose (editorial assessment)
Soft Chew 40–60% Limited by excipient mass High — probiotics require overdosing or encapsulation $0.30–$0.80
Powder (sachet or scoop) 5–15% High — most mass can be active Low — minimal heat processing $0.40–$1.20
Capsule 3–8% Very high — capsule shell is minimal Low — no thermal exposure $0.25–$0.70
Liquid Suspension 2–5% Very high — vehicle is inexpensive Variable — some heat processing for sterilization $0.50–$1.50

Scores and assessments in this table reflect editorial evaluation of publicly available manufacturing literature and contract-pricing norms. They are not derived from independent laboratory testing.

The honest read on soft chews

Soft chews are not inherently inferior. For ingredients that tolerate heat and moisture — vitamins, plant extracts, many postbiotics, collagen, omega-3 in protected forms — the format delivers acceptable active integrity at a convenient dose form. The format problem is specific to live cultures and heat-labile compounds, where the manufacturing economics create a structural disadvantage that marketing claims cannot fully overcome.

For consumers choosing supplements, the format question matters as much as the ingredient question. A premium soft chew with a modest dose of a well-tolerated active may deliver more value than a soft chew promising implausible CFU counts of a fragile strain. Conversely, a powder or capsule format may deliver a more honest product at a lower per-dose cost for ingredients that the soft chew process damages.

What This Means for the Shelf-Stability Investigation

The earlier soft chew CFU investigation on this site identified specific products where labeled claims appeared inconsistent with what the format could physically deliver. The manufacturing economics described here explain why: it is structurally very difficult to deliver high-count, multi-strain live probiotics through a soft chew at a competitive retail price without either accepting massive over-dosing costs or making stability compromises.

Brands that use postbiotic or heat-stable ingredients avoid this structural problem entirely. The format-versus-ingredient fit becomes a quality signal — when a soft chew product’s claims align with what the manufacturing process can preserve, credibility rises. When claims require the format to do something it structurally cannot do well, skepticism is warranted.

Frequently Asked Questions

Why do soft chews contain so much filler?

Soft chews require structural integrity, palatability, and moisture control. Achieving these physical properties demands 40–60% excipient mass — binders, humectants, flavors, and structural carbohydrates. The filler is not optional; it is the physical matrix that makes the format work.

Does the soft chew format damage probiotic bacteria?

Tunnel oven drying at 130–160°F exceeds the thermal tolerance of most probiotic organisms. Manufacturers compensate through overdosing (adding excess culture pre-processing) or encapsulation (coating cells in protective matrices). Neither strategy fully eliminates viability loss, which is why independent testing often finds soft chew CFU counts below label claims.

Are powders or capsules better than soft chews for probiotics?

For live bacterial cultures, powders and capsules generally preserve viability better because they avoid the thermal and moisture exposure of soft chew processing. The convenience advantage of chews comes with a structural cost in terms of what the format can reliably deliver. For heat-stable ingredients like postbiotics, the formats are more comparable.

How can consumers tell if a soft chew product’s claims are realistic?

Look for alignment between the format and the claimed active. Live, multi-strain, high-count probiotic claims on a soft chew should be viewed skeptically unless the manufacturer provides third-party shelf-stability data. Postbiotic, vitamin, plant extract, or heat-stable enzyme claims on a soft chew are more physically plausible given the format’s constraints.

References

  • Panzavecchia A, et al. Oral health outcomes in dogs supplemented with a postbiotic-prebiotic combination: a randomized controlled trial. J Vet Dent. 2026. PMID: 40509062
  • Santos R, et al. Gut-skin axis modulation by postbiotic supplementation in canine atopic dermatitis: a randomized clinical trial. Vet Dermatol. 2026. PMID: 40723482
  • USDA Food Safety and Inspection Service. Water Activity in Foods: Fundamentals and Applications. Technical Bulletin. 2024.
  • Tripathi MK, Giri SK. Probiotic functional foods: applications and challenges. J Food Sci Technol. 2023;60(4):1188-1200.

This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.




Similar Posts